Seeking Alpha

Shares of AngioDynamics (ANGO +2.4%) were roiled late in the trading day after the company cut...

Shares of AngioDynamics (ANGO +2.4%) were roiled late in the trading day after the company cut its FQ3 and FY revenue forecast and halted shipments of it NanoKnife ablation device in the U.S. due to a software recall. It now sees Q3 sales between $50M - $53M versus estimates of $53M, and 2012 sales of around $215M - $219M compared to expectations of $221M.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs